Sam Andrews, 53, a teaching assistant from Corsham in Wiltshire, was diagnosed with secondary breast cancer – which means the ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the ...

The University of Liverpool leads a €8.6M EU project using plant-based biomaterials to treat jawbone damage in cancer pa ...

Osteoporosis is a disease that makes bones weak and more likely to break. Sometimes, a person may break a bone from a small ...

The University of Liverpool is leading a major €8.6m (£7m) EU-funded research project to tackle a growing medical challenge ...

The University of Liverpool is leading a major €8.6m (£7m) EU-funded research project to tackle a growing medical challenge affecting thousands of cancer survivors: medication-related osteonecrosis of ...

Dental professionals are increasingly concerned about the serious complications that osteoporosis medications can cause in the jaw. Sandip Sachar, warned that drugs like bisphosphonates and denosumab ...

Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease. This finding comes ...

Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease. This finding ...

Osteonecrosis of the jaw is a rare but serious condition linked to medications such as bisphosphonates and denosumab. Patients with CKD, already prone to bone fragility due to mineral metabolism ...